Skip to main content

Flammer Martina M.D.'s Form 4 filing

INSMED IncINSM · filed Jan 6, 2026

Accession no.
0001796960-26-000002
Filed
Jan 6, 2026
Trade date
Jan 2-5, 2026
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 11 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.11M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Flammer Martina M.D.CIK 0001796960Officer (Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 2, 2026Common StockAGrant or awardAcquired+5,998–F2–89,109Direct
Jan 2, 2026Common StockAGrant or awardAcquired+5,645–F2–94,754Direct
Jan 5, 2026Common StockMOption exerciseAcquired+4,358$19.74+$86,026.9299,112Direct
Jan 5, 2026Common StockMOption exerciseAcquired+7,945$29.13+$231,437.85107,057Direct
Jan 5, 2026Common StockSSaleDisposed−2,799$169.29F5−$473,842.71104,258Direct
Jan 5, 2026Common StockSSaleDisposed−3,205$170.61F6−$546,805.05101,053Direct
Jan 5, 2026Common StockSSaleDisposed−2,836$171.19F7−$485,494.8498,217Direct
Jan 5, 2026Common StockSSaleDisposed−286$171.92−$49,169.1297,931Direct
Jan 5, 2026Common StockSSaleDisposed−1,820$173.45F8−$315,67996,111Direct
Jan 5, 2026Common StockSSaleDisposed−655$174.28F9−$114,153.495,456Direct
Jan 5, 2026Common StockSSaleDisposed−702$175.73F10−$123,362.4694,754Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 2, 2026Common StockAGrant or awardAcquired+31,280$0.00$031,280Direct
Jan 5, 2026Common StockMOption exerciseDisposed−4,358$0.00$08,715Direct
Jan 5, 2026Common StockMOption exerciseDisposed−7,945$0.00$031,780Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Each RSU was granted on January 2, 2026 for no consideration.

Referenced by the price of 2 transactions in Table I.

F5

This is the weighted average sales price representing 2,799 shares sold at prices ranging from $168.88 to $169.69 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F6

This is the weighted average sales price representing 3,205 shares sold at prices ranging from $169.91 to $170.90 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F7

This is the weighted average sales price representing 2,836 shares sold at prices ranging from $170.91 to $171.89 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F8

This is the weighted average sales price representing 1,820 shares sold at prices ranging from $173.05 to $173.87 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F9

This is the weighted average sales price representing 655 shares sold at prices ranging from $174.20 to $174.43 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F10

This is the weighted average sales price representing 702 shares sold at prices ranging from $175.54 to $176.12 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)